DK0564495T4 - Vævsfaktor-baseret prothrombintidsreagens - Google Patents

Vævsfaktor-baseret prothrombintidsreagens

Info

Publication number
DK0564495T4
DK0564495T4 DK92901065T DK92901065T DK0564495T4 DK 0564495 T4 DK0564495 T4 DK 0564495T4 DK 92901065 T DK92901065 T DK 92901065T DK 92901065 T DK92901065 T DK 92901065T DK 0564495 T4 DK0564495 T4 DK 0564495T4
Authority
DK
Denmark
Prior art keywords
tissue factor
prothrombin time
time reagent
based prothrombin
liposome compositions
Prior art date
Application number
DK92901065T
Other languages
Danish (da)
English (en)
Other versions
DK0564495T3 (da
Inventor
Scott Martin Brown
Original Assignee
Corvas Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27086686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0564495(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corvas Int Inc filed Critical Corvas Int Inc
Publication of DK0564495T3 publication Critical patent/DK0564495T3/da
Application granted granted Critical
Publication of DK0564495T4 publication Critical patent/DK0564495T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK92901065T 1990-11-13 1991-11-04 Vævsfaktor-baseret prothrombintidsreagens DK0564495T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61211890A 1990-11-13 1990-11-13
US07/784,326 US5314695A (en) 1990-11-13 1991-10-29 Tissue factor based prothrombin time reagent
PCT/US1991/008174 WO1992008479A1 (fr) 1990-11-13 1991-11-04 Reactif de temps de prothrombine base sur la thromboplastine tissulaire

Publications (2)

Publication Number Publication Date
DK0564495T3 DK0564495T3 (da) 1999-11-15
DK0564495T4 true DK0564495T4 (da) 2007-04-30

Family

ID=27086686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92901065T DK0564495T4 (da) 1990-11-13 1991-11-04 Vævsfaktor-baseret prothrombintidsreagens

Country Status (18)

Country Link
US (1) US5314695A (fr)
EP (1) EP0564495B2 (fr)
JP (1) JP3441456B2 (fr)
KR (1) KR100196107B1 (fr)
AT (1) ATE179608T1 (fr)
AU (2) AU9090791A (fr)
CA (1) CA2096109C (fr)
DE (1) DE69131204T3 (fr)
DK (1) DK0564495T4 (fr)
ES (1) ES2133310T5 (fr)
FI (1) FI109764B (fr)
GR (1) GR3030906T3 (fr)
IE (1) IE913955A1 (fr)
MX (1) MX9102042A (fr)
NO (1) NO314617B1 (fr)
NZ (2) NZ264556A (fr)
PT (1) PT99499B (fr)
WO (1) WO1992008479A1 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2097199C (fr) * 1991-10-04 2001-05-08 Pamela L. Hawkins Preparation de reactifs pour la determination du temps de prothrombine a partir d'un facteur tissulaire humain recombinant et de phospholipides synthetiques et naturels purifies
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5877289A (en) * 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
US6093399A (en) * 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
AU674139B2 (en) * 1992-04-13 1996-12-12 Ortho Diagnostic Systems Inc. Synthetic phospholipid reagent
EP0570356B1 (fr) * 1992-05-15 1999-02-17 IMMUNO Aktiengesellschaft Réactif pour la détermination du temps de thromboplastinee partiellement active (IIPa)
DE4243729A1 (de) * 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Reaktivierung von gereinigten Membranproteinen
PL181102B1 (pl) * 1993-01-29 2001-05-31 Dahlbaeck Bjoern Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
US7393682B1 (en) 1993-03-19 2008-07-01 The Johns Hopkins University School Of Medicine Polynucleotides encoding promyostatin polypeptides
US5780248A (en) 1993-07-15 1998-07-14 Ortho Diagnostic Systems, Inc. Foil sealed cassette for agglutination reactions and liner therefor
IL115849A0 (en) * 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
AT403437B (de) * 1995-02-15 1998-02-25 Immuno Ag Physiologisch aktive gewebefaktor-präparation
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
IL132529A0 (en) * 1997-04-23 2001-03-19 Instrumentation Lab Spa A method of preparing a liquid or a lyophilized reagent and a reagent produced thereby
DE19720853A1 (de) * 1997-05-17 1998-11-19 Dade Behring Marburg Gmbh Erhöhung der FVII Empfindlichkeit eines Thromboplastinreagenzes
US6891082B2 (en) 1997-08-01 2005-05-10 The Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a truncated activintype II receptor
US6656475B1 (en) 1997-08-01 2003-12-02 The Johns Hopkins University School Of Medicine Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
US6245573B1 (en) 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
DE19811016A1 (de) * 1998-03-13 1999-09-16 Dade Behring Marburg Gmbh Gebrauchsfertiges Prothrombinzeitreagenz auf der Basis von rekombinantem Gewebsfaktor
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
DE60011274T2 (de) * 1999-09-03 2005-07-07 Roche Diagnostics Corp., Indianapolis Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
US6576610B1 (en) 1999-10-04 2003-06-10 Nuvas, Llc Use of a context-dependent functional entity to enhance the efficacy of an agent
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US20030147944A1 (en) * 1999-12-10 2003-08-07 Mayer Lawrence D Lipid carrier compositions with protected surface reactive functions
US6855509B2 (en) * 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
EP2272946B9 (fr) 2002-02-25 2015-06-24 Vaxiion Therapeutics, LLC Compositions et méthodes de minicellules
WO2003078650A2 (fr) * 2002-03-12 2003-09-25 The Johns Hopkins University Regulation de l'activite de la transcriptase inverse par les ions manganeux et methodes de modulation de cette regulation
US20030232075A1 (en) * 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
US7049087B2 (en) * 2002-11-05 2006-05-23 Lifescan, Inc. Method for manufacturing a tissue factor-based prothrombin time reagent
WO2005014618A2 (fr) * 2003-08-08 2005-02-17 Immunomedics, Inc. Anticorps bispecifiques pour induire l'apoptose de cellules tumorales et malades
ATE395603T1 (de) * 2004-02-06 2008-05-15 Sysmex Corp Reagenziensatz zum nachweis von lupus- antikoagulant.
JP4617458B2 (ja) * 2004-02-10 2011-01-26 財団法人ヒューマンサイエンス振興財団 中空糸透析カラムを利用したリポソームの製造方法
US20050221414A1 (en) 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
US7635754B2 (en) * 2004-09-22 2009-12-22 Aerovance, Inc. Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
WO2006088741A2 (fr) * 2005-02-16 2006-08-24 The Board Of Trustees Of The University Of Illinois Procoagulant universel
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
CN101171034B (zh) 2005-03-03 2014-06-18 免疫医疗公司 人源化l243抗体
JP2008531692A (ja) * 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
JP2007091625A (ja) * 2005-09-28 2007-04-12 Shino Test Corp 血液凝固反応促進剤
JP5017622B2 (ja) * 2005-11-30 2012-09-05 株式会社シノテスト 血液凝固反応抑制剤
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US20120196827A1 (en) 2006-06-12 2012-08-02 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
JP5073270B2 (ja) * 2006-11-14 2012-11-14 シスメックス株式会社 凝固検査用試薬及びその製造方法
US8821861B2 (en) * 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (fr) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Antagoniste d'anticoagulant et procoagulant anti-hémophilique
KR20180013993A (ko) 2008-06-25 2018-02-07 벡션 테라퓨틱스 엘엘씨 조절된 유전자 자살 메커니즘 조성물 및 방법
EP2576813A1 (fr) 2010-05-28 2013-04-10 Diagon Kft. Procédé pour la préparation biphasique de liposomes et son utilisation dans la fabrication de réactifs de diagnostic
WO2012057765A1 (fr) 2010-10-28 2012-05-03 The Board Of Regents Of The University Of Texas System Anticorps monoclonaux recombinants anti-cd19
AU2012217728B2 (en) 2011-02-15 2017-04-27 Vaxiion Therapeutics, Llc Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
ES2806605T3 (es) 2011-09-23 2021-02-18 Univ Loma Linda Cepas bacterianas que expresan genes de metilasa y sus usos
CN102565427A (zh) * 2011-12-28 2012-07-11 苏州良辰生物医药科技有限公司 一种凝血酶原时间测定试剂的制备方法
WO2014039745A1 (fr) 2012-09-07 2014-03-13 Children's Medical Center Corporation Souris reporter spécifique de cellules souches hématopoïétiques et ses utilisations
KR102627631B1 (ko) 2012-10-02 2024-01-22 벡션 테라퓨틱스 엘엘씨 면역 조절성 미니세포 및 사용 방법
JP6250306B2 (ja) * 2013-05-28 2017-12-20 株式会社Ｌｓｉメディエンス リポ化トロンボプラスチン含有血液凝固能測定試薬及び測定方法
CN113577323B (zh) * 2015-08-04 2024-02-20 瓦克星治疗有限责任公司 基于细菌小细胞的生物药物的电离辐射灭菌以及使用方法
CN108603889B (zh) 2016-02-12 2021-08-31 仪器实验室公司 双组分“即混即用”液体促凝血酶原激酶试剂及其制造方法和使用方法
JP6652873B2 (ja) * 2016-03-30 2020-02-26 シスメックス株式会社 プロトロンビン時間測定用試薬、その製造方法およびプロトロンビン時間の測定方法
JP6626761B2 (ja) * 2016-03-30 2019-12-25 シスメックス株式会社 プロトロンビン時間測定用試薬およびその製造方法
AU2017365028A1 (en) 2016-11-23 2019-06-20 Vaxiion Therapeutics, Llc Immunomodulatory and oncolytic minicells and methods of use
CN106680339A (zh) * 2016-12-28 2017-05-17 北京乐普医疗科技有限责任公司 一种基于电化学方法的凝血酶原时间测试卡及其制备方法
CN109239373A (zh) * 2018-08-15 2019-01-18 迪瑞医疗科技股份有限公司 一种组织因子酯化物试剂及其制备方法与应用
CN109613279A (zh) * 2018-12-06 2019-04-12 太原博奥特生物技术有限公司 一种新型鞣花酸化合物及利用鞣花酸化合物制备活化部分凝血活酶时间测定试剂
CN110244066A (zh) * 2019-07-01 2019-09-17 北京乐普医疗科技有限责任公司 一种干式电化学法凝血酶原时间检测卡及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123584C (fr) * 1958-05-16
DE2916711A1 (de) † 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
IT1212900B (it) * 1983-11-17 1989-11-30 Valle Francesco Della Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein
IE81149B1 (en) † 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) † 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
US4865984A (en) † 1988-02-08 1989-09-12 Mount Sinai School Of Medicine Of The City University Of New York Dynamic continuous flow enzyme reactor

Also Published As

Publication number Publication date
GR3030906T3 (en) 1999-11-30
FI109764B (fi) 2002-10-15
CA2096109C (fr) 2004-01-06
DK0564495T3 (da) 1999-11-15
AU9090791A (en) 1992-06-11
EP0564495B2 (fr) 2006-12-27
NO931708D0 (no) 1993-05-11
FI932148A (fi) 1993-06-03
AU4448996A (en) 1996-05-09
FI932148A0 (fi) 1993-05-12
PT99499A (pt) 1992-11-30
NO931708L (no) 1993-07-08
MX9102042A (es) 1994-01-31
NO314617B1 (no) 2003-04-22
ATE179608T1 (de) 1999-05-15
US5314695A (en) 1994-05-24
JPH06502649A (ja) 1994-03-24
ES2133310T5 (es) 2007-08-16
ES2133310T3 (es) 1999-09-16
NZ264556A (en) 1996-07-26
DE69131204D1 (de) 1999-06-10
EP0564495B1 (fr) 1999-05-06
IE913955A1 (en) 1992-05-20
WO1992008479A1 (fr) 1992-05-29
NZ240577A (en) 1996-07-26
DE69131204T3 (de) 2007-05-24
KR100196107B1 (ko) 1999-06-15
EP0564495A1 (fr) 1993-10-13
JP3441456B2 (ja) 2003-09-02
EP0564495A4 (fr) 1994-12-21
PT99499B (pt) 1999-04-30
DE69131204T2 (de) 1999-12-23
CA2096109A1 (fr) 1992-05-14

Similar Documents

Publication Publication Date Title
DK0564495T3 (da) Vævsfaktor-baseret prothrombintidsreagens
EP0252685A3 (en) Diagnostic methods for detecting lymphomas in humans
KR880005921A (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
ATE330002T1 (de) Verfahren zur herstellung von membranvesikeln
ATE163768T1 (de) Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
IL70573A (en) Preparation of serum independent cell lines producing tissue plasminogen activator and/or pro-tissue plasminogen activator and said cell lines produced
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
IT8767610A0 (it) Particelle polimeriche prodotte per via sequenziale dispersioni acquose che le comprendono loro preparazione e impiego
PT84849A (pt) Enhanced expression of human interleukin-2 in mammalian cells
ATE73665T1 (de) Blutzellentrennung.
CA2019872A1 (fr) Methode et trousse pour la mesure de l'activite fonctionnelle de la proteine s dans le plasma humain
ATE127842T1 (de) Megakaryocytopoietin, seine herstellung und benutzung.
DE3584661D1 (de) In vitro-pruefverfahren zur bestimmung von augenschaedlichen eigenschaften.
JPS5681106A (en) Method of denaturing condition of diffusing membrane* diffusing membrane denatured in this manner and its use
FI882059A (fi) Menetelmä vierasproteiinien valmistamiseksi Streptomycessoluissa
DE69330611D1 (de) Verfahren zur identifikation von mit hiv infizierten personen und zur überwachung ihrer therapie
ES8704268A1 (es) Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.
Puskás et al. In vitro synthesis and identification of lysozyme in human tonsillar cells
IL84629A0 (en) Process and device for the cultivation of mammalian cells in a suspension culture,and their use for the preparation of proteins
JPS5639795A (en) Preparation of interferon
SU1268015A1 (ru) Способ определения кристаллографической неоднородности полупроводниковых кристаллических образцов
Schick et al. The Synthesis and Localization of Alternatively Spliced Fibronectin EIIIB in Resting and Thrombin-Treated Megakaryocytes
ATE85087T1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.
ATE5254T1 (de) Tripeptidderivate und verfahren zur bestimmung von enzymen mittels derselben.
IT1204109B (it) Metodo per la produzione e messa in opera rapida di tappeto erboso rimovibile